Bridgeworth, LLC Eli Lilly & CO Transaction History

Bridgeworth, LLC

$1.01 Billion
Q4 2023

A detailed history of Bridgeworth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bridgeworth, LLC holds 1,250 shares of LLY stock, worth $985,237. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,250

Previous 1,262 0.95%

Holding current value

$985,237

Previous $677,000 7.53%

% of portfolio

0.07%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $6,302 - $7,429	-12 Reduced 0.95%	1,250 $728,000
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $65,588 - $87,699	187 Added 17.4%	1,262 $591,000
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $237,010 - $278,357	-763 Reduced 41.51%	1,075 $369,000
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $964 - $1,124	3 Added 0.16%	1,838 $672,000
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $2,964 - $3,378	-10 Reduced 0.54%	1,835 $593,000
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $91,980 - $107,999	-330 Reduced 15.17%	1,845 $598,000
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $1,173 - $1,458	5 Added 0.23%	2,175 $623,000
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $1,124 - $1,395	5 Added 0.23%	2,170 $599,000
Q3 2021 Oct 21, 2021	SELL	$221.6 - $272.71 $19,944 - $24,543	-90 Reduced 3.99%	2,165 $500,000
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $902 - $1,167	5 Added 0.22%	2,255 $518,000
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $985 - $1,276	6 Added 0.27%	2,250 $420,000
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $1,435 - $1,898	-11 Reduced 0.49%	2,244 $379,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $1,023 - $1,183	7 Added 0.31%	2,255 $334,000
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $954 - $1,149	7 Added 0.31%	2,248 $369,000
Q1 2020 Apr 27, 2020	BUY	$119.05 - $147.35 $73,691 - $91,209	619 Added 38.16%	2,241 $311,000
Q4 2019 Jan 17, 2020	BUY	$106.92 - $132.43 $173,424 - $214,801	1,622 New	1,622 $213,000
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $269,537 - $293,187	-2,524 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$110.79 - $129.32 $15,732 - $18,363	-142 Reduced 5.33%	2,524 $280,000
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $14,692 - $17,294	132 Added 5.21%	2,666 $346,000
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $20,756 - $23,253	-196 Reduced 7.18%	2,534 $205,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $64,996 - $81,233	757 Added 38.37%	2,730 $212,000
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $71,385 - $81,927	-943 Reduced 32.34%	1,973 $168,000
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $216,396 - $255,441	2,916 New	2,916 $224,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeworth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeworth, LLC with notifications on news.

Account